相关实验视频

Updated: Jul 12, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

在患有状细胞病的成年人中,经过平分异性的造血干细胞移植后,大脑的血液动力学变化

Megan A Aumann¹, Wesley Richerson¹, Alexander K Song¹

¹Department of Neurology, Vanderbilt University Medical Center, Nashville, TN.

|October 26, 2023

概括

在患有状细胞病 (SCD) 的成年人中,造血干细胞移植 (HSCT) 将脑血流 (CBF) 的升高正常化到健康水平. 这种治疗有效地恢复正常的大脑血液动力学,而不会改变氧气提取或代谢率.

科学领域:

神经学神经学
血液学血液学血液学
医疗成像医学成像

背景情况:

状细胞疾病 (SCD) 与大脑血动力学异常有关.
以前的研究表明,造血干细胞移植 (HSCT) 可能改善SCD患者的大脑血液动力学.
大脑血流 (CBF),氧气提取率 (OEF) 和大脑氧气代谢率 (CMRO2) 是大脑健康的关键指标.

研究的目的:

为了研究 haploidentical 骨髓移植 (haplo-BMT) 对患有 SCD 的成年人大脑血液动力学的影响.
为了确定HSCT是否使CBF,OEF和CMRO2正常化到健康个体中所见的水平.
在这个患者群体中评估 haplo-BMT 的安全性和有效性.

主要方法:

磁共振成像 (MRI) 用于测量CBF,OEF和CMRO2在11名成年人中SCD之前和之后的Haplo-BMT.
测量结果与年龄,种族和性别匹配的健康对照进行了比较.
患者从一级亲属那里获得了强度降低的准备 haplo-BMT.

主要成果:

与对照组相比,SCD患者的移植前CBF显著升高.
移植后CBF显著下降,正常化到控制水平.
在Haplo-BMT后,OEF和CMRO2没有显著变化,并且与对照值保持可比性.
主要并发症包括一种感染相关的死亡和一种严重的慢性移植对宿主疾病.

结论:

哈普洛-BMT有效地将SCD成年人的CBF升高降低到正常水平.
该程序保持OEF和CMRO2在健康成年人观察到的水平.
在患有SCD的成年人中,HSCT是一种可行的治疗选择,可以使大脑血液动力学正常化.

更多相关视频

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

相关概念视频

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...